Search all trials

Find therapies in clinical trials near you – page 76

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Not recruiting

Registered drug

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Focal segmental glomerulosclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azilsartan Medoxomil

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Psoriasis

Not recruiting

InvestigationalNo placebo

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Risankizumab

Contact Research Centre

Lung adenocarcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Actinic cheilitis

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tirbanibulin

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 76

953 trials match your criteria

Pulmonary arterial hypertension

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Hepatocellular carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Focal segmental glomerulosclerosis

Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Ischaemic stroke

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Psoriasis

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Lung adenocarcinoma

Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

Actinic cheilitis

Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis

Acute myeloid leukaemia

Study of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.